Preclinical Toxicology Testing Services (in vitro)

A key part of the drug development cycle are preclinical toxicology and related safety. The studies are performed to demonstrate that the test compound is safe, and at what doses, for administration to humans as part of clinical trials. The FDA recommends these studies “to develop adequate data to undergird a decision that it is reasonably safe to proceed with human trials of the drug.” As clinical trials are expensive and time-consuming, companies that offer expertise in preclinical toxicology testing services can discover potential problems in drug development before clinical trials begin.